Cited by 39Hematopoietic Stem Cell TransplantationGut microbiota and healthNeutropenia and Cancer Infections

The association between the incidence of intestinal graft‐vs‐host disease and antibiotic use after allogeneic hematopoietic stem cell transplantation

Hidaka, Daisuke, Hayase, Eiko, Shiratori, Souichi, Hasegawa, Yuta, Ishio, Takashi, Tateno, Takahiro, Okada, Kohei, Goto, Hideki +7 more·2018·Clinical Transplantation

Abstract

Intestinal microbiota plays an important role in the regulation of allogeneic immune reaction after allogeneic hematopoietic stem cell transplantation (allo‐SCT). Intestinal graft‐vs‐host disease (GVHD) is one of the major causes of mortality after allo‐SCT and often complicated with intestinal dysbiosis. Recent studies suggest that antibiotic‐induced dysbiosis is a risk factor for intestinal GVHD. We retrospectively evaluated the impacts of antibiotic use on the incidence of intestinal GVHD occurring before day 100 after allo‐SCT. Among 213 patients who underwent allo‐SCT, 200 patients achieving engraftment were analyzed. Antibiotics were classified into carbapenem, quinolone, penicillin, cephem, and glycopeptide. Among 128 patients who developed acute GVHD, intestinal GVHD developed in 36 patients. Patients with intestinal GVHD received significantly longer administration of carbapenem and glycopeptide compared to those without it in periengraftment period. In multivariate analysis, use of carbapenem for greater than 7 days was associated with an increased risk of intestinal GVHD. However, use of antibiotics for greater than 7 days was not associated with poor overall survival and high nonrelapse mortality. Long use of carbapenem in periengraftment period may be a risk for intestinal GVHD. Prospective studies are required to validate our findings.

Integrity signals

Registry

Crossref · 10.1111/ctr.13361

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Single-center studies have linked post-HCT intestinal microbiota features to relapse, GVHD, infection, organ toxicity, and overall survival.

    “Each of these outcomes, as well as overall survival, has been associated in single-center studies with features of the intestinal microbiota in the period after hematopoietic-cell transplantation.2–4,8–15”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hidaka, D., Hayase, E., Shiratori, S., Hasegawa, Y., Ishio, T., Tateno, T., Okada, K., Goto, H., Sugita, J., Onozawa, M., Nakagawa, M., Kahata, K., Endo, T., Hashimoto, D., & Teshima, T.
Affiliations
Hokkaido University (JP)
Corresponding author
Hayase, Eiko
Venue
Clinical Transplantation
Publisher
Wiley
Published
2018-08-13
Volume
32
Issue
9
Pages
e13361-e13361
ISSN
  • 0902-0063 (ISSN-L)
  • 1399-0012
OpenAlex
W2884254533
Cited by
39
References
26
Citations by year
2026: 3 · 2025: 6 · 2024: 4 · 2023: 11 · 2022: 5 · 2021: 4 · 2020: 5 · 2019: 1
FWCI
1.79
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Transplantation (publishedVersion)
  • PubMed (publishedVersion)
Funders
Japan Society for the Promotion of Science (17H04206, 17K19641, 17K09945, 18K08313)
Topics
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
Keywords
gastrointestinal graft-versus-host disease, allogeneic hematopoietic stem cell transplantation, antibiotic use, carbapenems, gut dysbiosis, gut microbiota, overall survival, non-relapse mortality
MeSH terms
Gastrointestinal Microbiome, Adolescent, Adult, Aged, Anti-Bacterial Agents, Female, Follow-Up Studies, Graft vs Host Disease, Humans, Intestinal Diseases, Japan, Male, Middle Aged, Prognosis, Retrospective Studies, Risk Factors, Hematopoietic Stem Cell Transplantation, Hematologic Neoplasms, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review